SGHT
Sight Sciences, Inc. · Healthcare
Director and 10% owner Staffan Encrantz bought $116K of Sight Sciences, Inc.
Bought$115,963
$8.31Price
13,958Shares
What SGHT did for a copier
- $1,000 copied at Fri, Dec 19 open, $8.35
- $733
- S&P 500, same days
- +1.4%
Measured over 30 trading days, to the Feb 4 close.
Staffan Encrantz's record
8 other buys with 3 months of prices since 2021: on average −0.9% against the S&P 500, and 3 of 8 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Dec 16. Filed Thu, Dec 18, 6:10 PM ET, after the close. Returns use the Dec 19 open and the Feb 4 close. Not investment advice.